跳至主要内容
临床试验/JPRN-UMIN000012505
JPRN-UMIN000012505招募中未知

Feasibility study of adjuvant chemotherapy with nab-paclitaxel and carboplatin in patients with completely resected pathological IB squamous cell lung cancer, II and IIIA non-small cell lung cancer - Feasibility study of adjuvant nab-PTX/CBDCA for StageIB SqLC, II and IIIA NSCLC

Dokkyo Medical University department of General thoracic surgery0 个研究点目标入组 45 人开始时间: 2013年12月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Not recovered from surgical complications 2) Active infection such as bacterial infection 3) Patients with interstitial pneumonitis or pulmonary fibrosis, as determined by chest CT 4) patients with myocardial infraction within 6 months 5) Patients with uncontrolled complications 6) With the history of hypersensitivity for nab-paclitaxel or CBDCA 7) Grade 2 or greater peripheral neuropathy 8) Active concomitant malignancy 9) Pregnant females, nursing mothers, possibly pregnant females, females wishing to become pregnant and Males that are currently attempting to produce a pregnancy 10) Other conditions not suitable for this study

研究者

发起方
Dokkyo Medical University department of General thoracic surgery

相似试验